ÇÁ·Î±×·¥
3¿ù 15ÀÏ(±Ý) / DAY 1 | ||
08:30 ~ 09:00 | Registration | |
09:00 ~ 09:10 | Opening Ceremony | |
09:10 ~ 10:40 | Basic session ¥°- Microbiome | ÁÂÀå: Á¶È«·¡ (¿ï»êÀÇ´ë), ÀÌ»óÈ£ (°æÈñÀÇ´ë) |
09:10 ~ 9:40 | Microbiome meets cancer and immunology | ¹ÚÇѼö (±¤ÁÖ°ú±â¿ø) |
09:40 ~ 10:10 | Gut-microbiome derived metabolites and muscle aging: bench to bedside | ·ùµ¿·Ä (¼º±Õ°üÀÇ´ë) |
10:10 ~ 10:40 | Gut microbiome play pivotal roles in gut-liver-adipose axis to control metabolic homeostasis | Ȳ¼º¼ø (¿¬¼¼ÀÇ´ë) |
10:40 ~ 11:00 | Coffee Break | ¡¡ |
11:00 ~ 12:30 | Basic session ¥± - Bioinformatics | ÁÂÀå: ¹®Àμº (°¡Å縯ÀÇ´ë), ±Çº´¼® (¿ï»êÀÇ´ë) |
11:00 ~ 11:30 | Cell identities and driver mutations of thymic epithelial tumors | ÁÖ¿µ¼® (KAIST) |
11:30 ~ 12:00 | Systems biology approaches for better understanding biochemical reactions in the conteat of medicine | ±èÇö¿í (KAIST) |
12:00 ~ 12:30 | Iterative expansion microscopy: Molecular mapping of organs with nanoscale resolution¡¡ | ÀåÀç¹ü (KAIST) |
11:00 ~ 12:30 | À¯°ü±â°ü º¸°í | ÁÂÀå: ±èÀ¯¼± (¿¬¼¼ÀÇ´ë), ±Ç¿ÀÁ¤ (ÇѾçÀÇ´ë) |
11:00 ~ 11:30 | Vitallink | ¾È±Ô¸® (¼¿ïÀÇ´ë) |
11:30 ~ 12:00 | KODA | Á¶¿øÇö (°è¸íÀÇ´ë) |
12:00 ~ 12:30 | KOTRY | ±è¸í¼ö (¿¬¼¼ÀÇ´ë) |
12:30 ~ 13:30 | Luncheon Symposium | ¡¡ |
13:30 ~ 15:00 | Basic session ¥² - MDSC and MSC | ÁÂÀå: ÃÖ°æÈ£ (¼¿ïÀÇ´ë), ÀÌ»ï¿ (ÇѸ²ÀÇ´ë) |
13:30 ~ 14:00 | Introduciton to MDSC regulation | ¹Ú¼º±Ô (±¤ÁÖ°ú±â¿ø) |
14:00 ~ 14:30 | Adoptive cellular therapy using MDSCs expanded from cord blood | ±èÅÂ±Ô (°¡Å縯ÀÇ´ë) |
14:30 ~ 15:00 | ¸é¿ªÁúȯ Ä¡·á¸¦ À§ÇÑ 'ÃþºÐ¸®¹è¾ç¹ý' ºÐ¸®±â¼ú ±â¹Ý °í¼øµµ Áß°£¿±Áٱ⼼Æ÷ Ä¡·áÁ¦ °³¹ß | ¼Û¼ø¿í (ÀÎÇÏÀÇ´ë) |
13:30 ~ 15:00 | Á¤Ã¥¼¼¼Ç - ³ú»çÀÇ »ç¸ÁÀÎÁ¤°ú ÀÌ¿¡ µû¸£´Â ¹®Á¦ | ÁÂÀå: ±èÀçÁß (¿ï»êÀÇ´ë), ¿Àâ±Ç (¾ÆÁÖÀÇ´ë) |
13:30 ~ 13:50 | »ç¸ÁÀÇ Á¤ÀÇ | ÇÏÁ¾¿ø (¼¿ïÀÇ´ë) |
13:50 ~ 14:10 | Çü¹ý, ¹Î¹ý¿¡¼ ¿¹»óµÇ´Â ¹®Á¦Á¡ | ÁÖÈ£³ë (°æÈñ¹ý´ë) |
14:10 ~ 14:30 | À±¸®Àû ½Ã°¢ | ±¸ÀÎȸ (°¡Å縯´ë) |
14:30 ~ 14:50 | Á¾±³Àû ½Ã°¢ | ¾È½Å±â (¿¬¼¼ÀÇ´ë) |
14:50 ~ 15:00 | Q & A | |
15:00 ~ 15:20 | Coffee Break | ¡¡ |
15:20 ~ 17:00 | ±³À°¼¼¼Ç - ³ú»çÀÚ Àå±â±âÁõÀÚ¿¡ ´ëÇÑ ¿¹¿ì | ÁÂÀå: À¯Èñö (ÀüºÏÀÇ´ë), ±è¿µÈÆ (ÀÎÁ¦ÀÇ´ë) |
15:20 ~ 15:40 | ÇöȲ | ÀÌ½Ä (ÀüºÏÀÇ´ë) |
15:40 ~ 16:00 | ¹®Á¦Á¡: Áõ·Êº¸°í | ±èÇü¼÷ (¼¿ï¼º¸ðº´¿ø) |
16:00 ~ 16:20 | »õ·Î¿î ¹æ¾È | ÁÖ¸¸±â (¿¬¼¼ÀÇ´ë) |
16:20 ~ 17:00 | Panel discussion | ¡¡ |
¡¡ | Panel: ¾ÈÇüÁØ (°æÈñÀÇ´ë), ÀÌÁ¤¸² (KODA), ÃÖ¿øÁØ (KONOS), ¼Õ¼±¿µ (°³²¼¼ºê¶õ½ºº´¿ø) | ¡¡ |
15:20 ~ 17:00 | ÆíÁý¼¼¼Ç: À̽ÄÇÐȸÁö, ¿µÇâ·ÂÀÖ´Â ÇмúÁö ¸¸µé±â | ÁÂÀå: ±è¼øÀÏ (¿¬¼¼ÀÇ´ë), ÇÏÁ¾¿ø (¼¿ïÀÇ´ë) |
15:20 ~ 15:50 | ÁÁÀº ÇмúÁö¸¦ ¸¸µé±â À§ÇÑ ÆíÁýÀÎÀÇ ¿ªÇÒ | Çã¼± (ÇѸ²ÀÇ´ë) |
15:50 ~ 16:10 | SCIE µîÀç °æÇè(KJIM) | ¾çö¿ì (°¡Å縯ÀÇ´ë) |
16:10 ~ 16:30 | À̽ÄÇÐȸÁöÀÇ ÇöÀç¿Í ³ª¾Æ°¡¾ßÇÒ ¹Ì·¡ | À±ÀÍÁø (°Ç±¹ÀÇ´ë) |
16:30 ~ 17:00 | Pannel discussion | ¡¡ |
¡¡ | Panel: ±è¸í¼ö (¿¬¼¼ÀÇ´ë), ¿ÀÀºÁö (°¡Å縯ÀÇ´ë), ¾çö¿ì (°¡Å縯ÀÇ´ë), À±ÀÍÁø (°Ç±¹ÀÇ´ë), Çã¼± (ÇѸ²ÀÇ´ë) | ¡¡ |
17:00 | Closing | ¡¡ |
3¿ù 16ÀÏ(Åä) / DAY 2 | |||
07:30 ~ 08:00 | Registration | ||
08:00 ~ 09:00 | ¿¬±¸ °úÁ¦ ¹× ÀåÇÐ±Ý º¸°í | ÁÂÀå: ±èº´Ã¢ (¸Þ¸®³îº´¿ø), ±è»óÀÏ (°¡Å縯ÀÇ´ë) |
|
08:00 ~ 08:20 | Áã ½ÅÀåÀÇ ÇãÇ÷ Àç°ü·ù ¼Õ»ó¿¡¼ »êÈÁú¼Ò(nitric oxide, NO)ÀÇ ¿¹¹æ È¿°ú¿¡ °üÇÑ ¿¬±¸ | ¾ÈÇüÁØ (°æÈñÀÇ´ë) | |
08:20 ~ 08:40 | ½ÉÀåÀÌ½Ä È¯ÀÚ¿¡¼ CMV ƯÀÌ T¼¼Æ÷ ¹ÝÀÀºÐ¼®À» ÅëÇÑ ¸é¿ª¾ïÁ¦ Á¤µµ ÃøÁ¤¹æ¹ý È®¸³ | À±Á¾Âù (ÇѸ²ÀÇ´ë) | |
08:40 ~ 09:00 | ´ç´¢ Áã ½ÅÀåÀÇ ÇãÇ÷-Àç°ü·ù ¼Õ»ó ½Ã DexmedetomidineÀÌ ½Å±â´É º¸È£¿¡ ¹ÌÄ¡´Â È¿°ú ¿¬±¸ | ÃÖ¿ë¼± (¿¬¼¼ÀÇ´ë) | |
09:00 ~ 10:30 | À±¸®¼¼¼Ç - »ýüÀ̽Ŀ¡¼ ¹Ì¼º³âÀÚ Àå±â±âÁõ½Ã À±¸®ÀûÀÎ ¹®Á¦ | ÁÂÀå: ¾çö¿ì (°¡Å縯ÀÇ´ë), ±èÇüÅ (°è¸íÀÇ´ë) |
|
09:00 ~ 09:20 | Medical issue | Ȳ½Å (¿ï»êÀÇ´ë) | |
09:20 ~ 09:40 | Practical issue | ±èº¹³à (»ï¼º¼¿ïº´¿ø) | |
09:40 ~ 10:00 | Legal issue | Á¶¼º¿ë (ÇÑÀϹý·ü¹®Á¦¿¬±¸¼Ò) | |
10:00 ~ 10:30 | Panel discussion | ¡¡ | |
¡¡ | Panel: Ȳ½Å (¿ï»êÀÇ´ë), ±èº¹³à (»ï¼º¼¿ïº´¿ø), Á¶¼º¿ë (ÇÑÀϹý·ü¿¬±¸¼Ò), ¼¸í¿ë (Áúº´°ü¸®º»ºÎ) | ¡¡ | |
10:30 ~ 10:50 | Coffee Break | ¡¡ | |
10:50 ~ 12:20 | Plenary Session | ÁÂÀå: ±è¼øÀÏ(¿¬¼¼ÀÇ´ë) | |
10:50 ~ 11:20 | Living liver donors in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study | Z. Butt (Northwestern Univ)¡¡ | |
11:20 ~ 11;50 | ÀÇ·áÀÌ¿ëµ¥ÀÌÅ͸¦ ÀÌ¿ëÇÑ À̽ĺо߿¡¼ÀÇ ¿¬±¸ÀÇ ¹æÇâ°ú Á¦ÇÑÁ¡ | ±èÇöÁ¤ (°í·ÁÀÇ´ë)¡¡ | |
11:50 ~ 12:20 | Modulation of host immunity by Treg-inducing probiotics¡¡ | ÀÓ½ÅÇõ (Æ÷Ç×°ø´ë)¡¡ | |
12:20 ~ 12:40 | ÀÓ½ÃÃÑȸ | ¡¡ | |
12:40 ~ 13:40 | Luncheon Symposium | ¡¡ | |
Concurrent Symposium |
13:40 ~ 15:10 | Concurrent Symposium I - De novo DSA in kidney transplantation: A to Z | ÁÂÀå: ÀÌÁ¾¼ö (¿ï»êÀÇ´ë), ÃÖ¼öÁø³ª (Àü³²ÀÇ´ë) |
13:40 ~ 14:10 | HLA epitope analysis and pathogenesis of de novo DSA | ½ÅÈ£½Ä (°í½ÅÀÇ´ë) | |
14:10 ~ 14:40 | Prediction of De novo DSA: Eplet risk stratification | ÀÌÁ¾¼ö (¿ï»êÀÇ´ë) | |
14:40 ~ 15:10 | Treat or not to treat de novo DSA positive patients | ¾çÀç¼® (¼¿ïÀÇ´ë) | |
13:40 ~ 15:10 | Concurrent Symposium II - Recurrence and management after liver transplantation | ÁÂÀå: Á¶Àç¿ø (¼º±Õ°üÀÇ´ë), ¼°æ¼® (¼¿ïÀÇ´ë) |
|
13:40 ~ 14:00 | Primary liver cancer | Á¤µ¿È¯ (¿ï»êÀÇ´ë) | |
14:00 ~ 14:20 | Viral disease (HBV, HCV, and HEV) | ¹ÚÁØ¿ë (¿¬¼¼ÀÇ´ë) | |
14:20 ~ 14:40 | Autoimmune liver disease | Á¤¼÷Çâ (¼¿ïÀÇ´ë) | |
14:40 ~ 15:00 | LT using grafts with metabolic disorders | À̳²ÁØ (¼¿ïÀÇ´ë) | |
15:00 ~ 15:10 | Q & A | ¡¡ | |
13:40 ~ 15:10 | Concurrent Symposium III - Review of candidates for thoracic transplantation | ÁÂÀå: ±è±âºÀ (¼¿ïÀÇ´ë), ¹Ú¹«¼® (¿¬¼¼ÀÇ´ë) |
|
13:40 ~ 14:00 | Cardiac amyloidosis | ÃÖÈ¿ÀÎ (¿ï»êÀÇ´ë) | |
14:00 ~ 14:20 | Candidate with significant pulmonary hypertension | ÃÖÁø¿À (¼º±Õ°üÀÇ´ë) | |
14:20 ~ 14:40 | Connective tissue diseases that involoving lung | °û½Â±â (°¡Å縯ÀÇ´ë) | |
14:40 ~ 15:00 | Hematologic malignancies that develop bronchiolitis obliterance after bone marrow transplantation | ±è¼öÁ¤ (¿¬¼¼ÀÇ´ë) | |
15:00 ~ 15:10 | Panel discussion | ||
Panel: ¿ÀÀç¿ø (¿¬¼¼ÀÇ´ë), Àü°æ¸¸ (¼º±Õ°üÀÇ´ë) | |||
15:10 ~ 15:30 | Coffee Break | ||
Concurrent Symposium |
15:30 ~ 17:00 | Concurrent Symposium IV - Banff update | ÁÂÀå: ¼±¤¼± (Ãæ³²ÀÇ´ë), ¾ÈÇüÁØ (°æÈñÀÇ´ë) |
15:30 ~ 16:00 | Banff ºÐ·ùÀÇ ¿ª»ç ¹× °³¿ä | ±Ç±â¿µ (¼º±Õ°üÀÇ´ë) | |
16:00 ~ 16:30 | Updates on ABMR including C4d-negative ABMR | ¹®°æö (¼¿ïÀÇ´ë) | |
16:30 ~ 17:00 | Chronic TCMR | ÇѸ¸ÈÆ (°æºÏÀÇ´ë) | |
15:30 ~ 17:00 | Concurrent Symposium V - Interpretation for marginal graft | ÁÂÀå: À¯¿µ°æ (°¡Å縯ÀÇ´ë), Ȳ½Å (¿ï»êÀÇ´ë) |
|
15:30 ~ 15:45 | Surgeon's view | ÃÖ±Ô¼º (¼º±Õ°üÀÇ´ë) | |
15:45 ~ 16:15 | what, how, why, cooperation with a physician | ÀÓ¼±¿µ (°í·ÁÀÇ´ë) | |
16:15 ~ 16:45 | Laboratory features of transplant suitability | ÀÌÇý¿µ (°¡Å縯°üµ¿ÀÇ´ë) | |
16:45 ~ 17:00 | Case review and discussion | È«±Ù (ÀÌÈÀÇ´ë) | |
15:30 ~ 17:00 | Concurrent Symposium VI - Living donors | ÁÂÀå: Àü°æ¿Á (½ÅÃ̼¼ºê¶õ½ºº´¿ø),
¿ÀÂ÷Àº (ºÀ»ýº´¿ø) |
|
15:30 ~ 16:05 | Donor evaluation and postopeative management in kidney transplantation | ÇÑ¿õ±Ô (¿¬¼¼ÀÇ´ë) | |
15:05 ~ 16:40 | Donor evaluation and postopeative management in liver transplantation | ÃÖ±Ô¼º (¼º±Õ°üÀÇ´ë) | |
16:40 ~ 17:00 | Q&A about living donor - º¸Çè, ºñ¿ë, À¯±ÞÈÞ°¡½Åû, ±âÁõ ÈÄ °Ç°°ü¸® | ±èÀοÁ (¼¿ï¾Æ»êº´¿ø) | |
17:00 ~ 17:15 | Closing |